Multibase India [MULTIBASE] vs Neogen Chemicals [NEOGEN] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Multibase India Ltd. wins in 16 metrics, Neogen Chemicals Ltd. wins in 3 metrics, with 1 ties. Multibase India Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Multibase India Ltd. | Neogen Chemicals Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 20.85 | 222.22 | Multibase India Ltd. |
| Price-to-Book Ratio | 3.11 | 5.46 | Multibase India Ltd. |
| Debt-to-Equity Ratio | 0.00 | 141.47 | Tie |
| PEG Ratio | 0.54 | -3.52 | Multibase India Ltd. |
| EV/EBITDA | 13.37 | 42.55 | Multibase India Ltd. |
| Profit Margin (TTM) | 19.31% | 2.41% | Multibase India Ltd. |
| Operating Margin (TTM) | 26.38% | 11.39% | Multibase India Ltd. |
| EBITDA Margin (TTM) | 26.38% | 11.39% | Multibase India Ltd. |
| Return on Equity | 18.67% | 4.41% | Multibase India Ltd. |
| Return on Assets (TTM) | 16.54% | 1.99% | Multibase India Ltd. |
| Free Cash Flow (TTM) | $36.32M | $-1.22B | Multibase India Ltd. |
| Dividend Yield | 20.05% | 0.19% | Multibase India Ltd. |
| 1-Year Return | -34.97% | 22.53% | Neogen Chemicals Ltd. |
| Price-to-Sales Ratio (TTM) | 4.02 | 5.56 | Multibase India Ltd. |
| Enterprise Value | $1.99B | $53.55B | Neogen Chemicals Ltd. |
| EV/Revenue Ratio | 3.07 | 6.55 | Multibase India Ltd. |
| Gross Profit Margin (TTM) | 50.22% | 47.11% | Multibase India Ltd. |
| Revenue per Share (TTM) | $51 | $310 | Neogen Chemicals Ltd. |
| Earnings per Share (Diluted) | $9.90 | $7.47 | Multibase India Ltd. |
| Beta (Stock Volatility) | 0.19 | 0.22 | Multibase India Ltd. |
Multibase India Ltd. vs Neogen Chemicals Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Multibase India Ltd. | -0.41% | -4.27% | -4.72% | 10.07% | -16.99% | -15.15% |
| Neogen Chemicals Ltd. | 1.51% | 8.10% | 24.00% | 48.67% | 91.41% | 75.54% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Multibase India Ltd. | -34.97% | -16.46% | -20.28% | -22.13% | 497.54% | 138.70% |
| Neogen Chemicals Ltd. | 22.53% | 26.54% | 147.06% | 676.07% | 676.07% | 676.07% |
Performance & Financial Health Analysis: Multibase India Ltd. vs Neogen Chemicals Ltd.
| Metric | MULTIBASE | NEOGEN |
|---|---|---|
| Market Information | ||
| Market Cap | ₹2.51B | ₹44.76B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 6,318 | 170,744 |
| 90 Day Avg. Volume | 10,909 | 127,390 |
| Last Close | ₹181.50 | ₹2,064.40 |
| 52 Week Range | ₹156.00 - ₹300.95 | ₹966.70 - ₹2,087.30 |
| % from 52W High | -39.69% | -1.10% |
| All-Time High | ₹779.00 (Dec 18, 2017) | ₹2,420.00 (Dec 09, 2024) |
| % from All-Time High | -76.70% | -14.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.21% | 0.09% |
| Quarterly Earnings Growth | 0.38% | -0.63% |
| Financial Health | ||
| Profit Margin (TTM) | 0.19% | 0.02% |
| Operating Margin (TTM) | 0.26% | 0.11% |
| Return on Equity (TTM) | 0.19% | 0.04% |
| Debt to Equity (MRQ) | 0.00 | 141.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹66.34 | ₹303.78 |
| Cash per Share (MRQ) | ₹44.87 | ₹57.58 |
| Operating Cash Flow (TTM) | ₹109.73M | ₹645.50M |
| Levered Free Cash Flow (TTM) | ₹146.55M | ₹348.30M |
| Dividends | ||
| Last 12-Month Dividend Yield | 20.05% | 0.19% |
| Last 12-Month Dividend | ₹56.00 | ₹3.00 |
Valuation & Enterprise Metrics Analysis: Multibase India Ltd. vs Neogen Chemicals Ltd.
| Metric | MULTIBASE (Apr 24, 2026) | NEOGEN (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 20.85 | 222.22 |
| Forward P/E | 9.50 | 72.26 |
| PEG Ratio | 0.54 | -3.52 |
| Price to Sales (TTM) | 4.02 | 5.56 |
| Price to Book (MRQ) | 3.11 | 5.46 |
| Market Capitalization | ||
| Market Capitalization | ₹2.51B | ₹44.76B |
| Enterprise Value | ₹1.99B | ₹53.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.07 | 6.55 |
| Enterprise to EBITDA | 13.37 | 42.55 |
| Risk & Other Metrics | ||
| Beta | 0.19 | 0.22 |
| Book Value per Share (MRQ) | ₹66.34 | ₹303.78 |
Financial Statements Comparison: Multibase India Ltd. vs Neogen Chemicals Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MULTIBASE (2025) | NEOGEN (2025) |
|---|---|---|
| Revenue/Sales | 707.49M | 7.58B |
| Cost of Goods Sold | 454.48M | 4.44B |
| COGS % of Revenue | 64.2% | 58.6% |
| Gross Profit | 253.01M | 3.13B |
| Gross Margin | 35.8% | 41.4% |
| Research & Development | N/A | 11.50M |
| Operating Income (EBIT) | 139.64M | 1.09B |
| Operating Margin | 19.7% | 14.4% |
| EBITDA | 208.87M | 1.31B |
| EBITDA Margin | 29.5% | 17.3% |
| Pre-Tax Income | 196.94M | 501.60M |
| Pre-Tax Income % of Revenue | 27.8% | 6.6% |
| Income Tax | 50.39M | 153.30M |
| Income Tax % of Revenue | 7.1% | 2.0% |
| Net Income (Profit) | 146.55M | 348.30M |
| Profit Margin | 20.7% | 4.6% |
Balance Sheet & Liquidity Metrics
| Metric | MULTIBASE (2025) | NEOGEN (2025) |
|---|---|---|
| Cash & Equivalents | 484.80M | 49.60M |
| Total Current Assets | 755.47M | 10.00B |
| Total Current Assets % of Revenue | 106.8% | 132.0% |
| Total Current Liabilities | 81.96M | 7.33B |
| Total Current Liabilities % of Revenue | 11.6% | 96.8% |
| Long-Term Debt | N/A | 1.94B |
| Long-Term Debt % of Revenue | 0.0% | 25.6% |
| Total Shareholders Equity | 785.10M | 7.89B |
| Retained Earnings | 646.52M | 2.28B |
| Retained Earnings % of Revenue | 91.4% | 30.1% |
| Property, Plant & Equipment | 23.91M | 890.30M |
Cash Flow Statement Comparison
| Metric | MULTIBASE (2025) | NEOGEN (2025) |
|---|---|---|
| Operating Cash Flow | 109.73M | 645.50M |
| Operating Cash Flow % of Revenue | 15.5% | 8.5% |
| Capital Expenditures | -21.61M | -3.17B |
| Free Cash Flow | 36.32M | -1.22B |
| FCF Margin | 5.1% | -16.1% |
| Debt Repayment | N/A | -718.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MULTIBASE | NEOGEN |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 12.62M | 27.38M |
| Float Shares | 3.00M | 13.28M |
| % Held by Insiders | 75.00% | 53.98% |
| % Held by Institutions | 0.00% | 23.81% |
| % Held by Public | 25.00% | 22.21% |
Dividend Analysis & Yield Comparison: Multibase India Ltd. vs Neogen Chemicals Ltd.
| Metric | MULTIBASE | NEOGEN |
|---|---|---|
| Last 12-Month Dividend | ₹56.00 | ₹3.00 |
| Last 12-Month Dividend Yield | 20.05% | 0.19% |
| 3-Year Avg Annual Dividend | ₹19.67 | ₹2.00 |
| 3-Year Avg Dividend Yield | 3.61% | 0.11% |
| 3-Year Total Dividends | ₹59.00 | ₹6.00 |
| Ex-Dividend Date | Nov 27, 2024 | Sep 19, 2025 |